I doubt it would ever happen, as IMU probably wouldn't want to...

I doubt it would ever happen, as IMU probably wouldn't want to risk cannibalising their own onCARlytics potential market.

But how good would a CF33 + IBX SPIONs + magnetic hyperthermia be?

Identify a useful antigen-antibody combo. Use CF33 virus to get cancer cells to express the antigen. Send antibody covered SPIONs in to bind to cancer cells. Then magnetic hyperthermia treatment.

Does anyone know if the NewPhase Ltd IP around SPIONs and magnetic hyperthermia is wrapped up tight, or is there some potential for new players to put their spin on it?

Maybe the potential PAB-IBX product could be used for magnetic hyperthermia.